TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/30/19 17:25 | 5/29/19 | NOVN | Novan, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Martin G. Kelly | NC | DO | CEO | P | 3 | 1.97 | 0 | 2 | 1 | 105 | I | ||||||||||||||
5/29/19 09:00 | 5/28/19 | NOVN | Novan, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Martin G. Kelly | NC | DO | CEO | P | 8 | 2.15 | 0 | 4 | 4 | 104 | I | ||||||||||||||
5/21/19 16:51 | 5/17/19 | NOVN | Novan, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Martin G. Kelly | NC | DO | CEO | P | 86 | 1.43 | 0 | 60 | 150 | 100 | M | ||||||||||||||
9/27/18 16:24 | 9/26/18 | NOVN | Novan, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Martin G. Kelly | NC | DO | CEO | P | 27 | 2.73 | 0 | 10 | 33 | 40 | D | ||||||||||||||
8/23/18 16:32 | 8/21/18 | NOVN | Novan, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Martin G. Kelly | NC | DO | CEO | P | 81 | 2.71 | 0 | 30 | New | 30 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |